RhumbLine Advisers’s Signify Health, Inc. SGFY Stock Holding History

RhumbLine Advisers’s Portfolio SGFY Stock Details SGFY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-93,674	Closed	-$2.69M	–	2975
2022 Q4	$2.69M	Buy	93,674 +20,486	+28%	+$591K	﹤0.01%	1628
2022 Q3	$2.13M	Buy	73,188 +9,712	+15%	+$224K	﹤0.01%	1724
2022 Q2	$876K	Buy	63,476 +19,341	+44%	+$272K	﹤0.01%	2211
2022 Q1	$801K	Sell	44,135 -12,349	-22%	-$177K	﹤0.01%	2223
2021 Q4	$803K	Buy	56,484 +14,893	+36%	+$230K	﹤0.01%	2301
2021 Q3	$743K	Buy	41,591 +21,150	+103%	+$544K	﹤0.01%	2363
2021 Q2	$622K	Buy	20,441 +3,678	+22%	+$101K	﹤0.01%	2458
2021 Q1	$490K	Buy	+16,763	New	+$519K	﹤0.01%	2509

Other funds holding SGFY

BHCM

Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

RhumbLine Advisers's SGFY Position: Q1 2023 in Review

RhumbLine Advisers sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 93,674 shares — an estimated $2.69M sold.

RhumbLine Advisers first reported a position in SGFY in Q1 2021 and held it in 8 quarters. The position peaked at $2.69M in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

RhumbLine Advisers reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
RhumbLine Advisers sold 93,674 Signify Health, Inc. shares in Q1 2023, an estimated $2.69M.
RhumbLine Advisers first reported a position in Signify Health, Inc. in Q1 2021 and held it in 8 quarters.
RhumbLine Advisers's Signify Health, Inc. position peaked at $2.69M in Q4 2022.
5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.